Taking Action Against Skin Cancer and Misleading Labels – APhA submits compounding comments to FDA.

7Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Taking Action Against Skin Cancer and Misleading Labels – APhA submits compounding comments to FDA. – (866) 348-2889.

The FDA is taking new steps to ensure products being marketed to protect consumers from the sun’s harmful effects deliver on their promises. FDA Commissioner Scott Gottlieb, MD, announced several new initiatives this week, while also promoting the National Council on Skin Care Prevention’s annual Don’t Fry Day.

Exposure to natural and artificial ultraviolet (UV) light has a direct impact on a person’s risk of developing skin cancer— the most common form of cancer in the United States.1 It is estimated that 1 individual dies from skin cancer every hour in the United States,2 and 1 of 5 Americans are estimated to be at risk of developing skin cancer in their lifetime.1 Skin cancer rates are increasing in the United States, and it is estimated that there will be more than 73,870 new cases of malignant melanoma this year, as well as more than 2 million new cases of basel cell, and squamous cell skin cancers.2 Most cases of melanoma, the deadliest form of skin cancer, can be attributed to UV exposure.

The effects of exposure to UV radiation from the sun or indoor tanning beds are cumulative, adding up over a lifetime.1 Advancing better UV protection has been a key goal of efforts by the healthcare community, and government agencies in recent years, Gottlieb said in a statement.1


This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.